Impact of cigarette smoking on the gastrointestinal tract inflammation: Opposing effects in Crohn's disease and ulcerative colitis

Frontiers in Immunology

Volumn 9, Issue JAN, 2018, Pages

  Berkowitz, Loni ^a,b   Schultz, Bárbara M ^a   Salazar, Geraldyne A ^a   Pardo Roa, Catalina ^a   Sebastián, Valentina P ^a   Álvarez Lobos, Manuel M ^b   Bueno, Susan M ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Cigarette smoking; Crohn's disease; Gastrointestinal inflammation; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 14; INTERLEUKIN 17; INTERLEUKIN 4; MURAMYL DIPEPTIDE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; AUTOPHAGY; CIGARETTE SMOKING; COLITIS; CROHN DISEASE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ENDOPLASMIC RETICULUM STRESS; ENTEROBACTERIACEAE; HELICOBACTER INFECTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IRRITABLE COLON; NONHUMAN; PROCTITIS; REMISSION; REVIEW; RUMINOCOCCUS; ULCERATIVE COLITIS;

EID: 85041589534     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.00074     Document Type: Review

References (84)

1. Csordas A, Bernhard D. The biology behind the atherothrombotic effects of cigarette smoke. Nat Rev Cardiol (2013) 10:219-30. doi:10.1038/nrcardio.2013.8
2. Stämpfli MR, Anderson GP. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol (2009) 9:377-84. doi:10.1038/nri2530
3. Marcilla A, Martínez I, Berenguer D, Gómez-Siurana A, Beltrán MI. Comparative study of the main characteristics and composition of the mainstream smoke of ten cigarette brands sold in Spain. Food Chem Toxicol (2012) 50:1317-33. doi:10.1016/j.fct.2012.01.046
4. Jaimes EA, DeMaster EG, Tian R-X, Raij L. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol (2004) 24:1031-6. doi:10.1161/01.ATV.0000127083.88549.58
5. Li LF, Chan RL, Lu L, Shen J, Zhang L, Wu WK, et al. Cigarette smoking and gastrointestinal diseases: the causal relationship and underlying molecular mechanisms (review). Int J Mol Med (2014) 34:372-80. doi:10.3892/ijmm.2014.1786
6. Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet (2011) 378:1015-26. doi:10.1016/S0140-6736(11)60988-4
7. World Health Organization. Tabaco. (2015). Available from: http://www.who.int/mediacentre/factsheets/fs339/es/
8. Li H, Wu Q, Xu L, Li X, Duan J, Zhan J, et al. Increased oxidative stress and disrupted small intestinal tight junctions in cigarette smoke-exposed rats. Mol Med Rep (2015) 11:4639-44. doi:10.3892/mmr.2015.3234
9. Yang S, Valvo S, Yao H, Kode A, Rajendrasozhan S, Edirisinghe I, et al. IKKa causes chromatin modification on pro-inflammatory genes by cigarette smoke in mouse lung. Am J Respir Cell Mol Biol (2008) 38:689-98. doi:10.1165/rcmb.2007-0379OC
10. Zhang L, Ren JW, Wong CC, Wu WK, Ren SX, Shen J, et al. Effects of cigarette smoke and its active components on ulcer formation and healing in the gastrointestinal mucosa. Curr Med Chem (2012) 19:63-9. doi:10.2174/092986712803413926
11. Ma L, Wang WP, Chow JY, Yuen ST, Cho CH. Reduction of EGF is associated with the delay of ulcer healing by cigarette smoking. Am J Physiol Gastrointest Liver Physiol (2000) 278:G10-7. doi:10.1152/ajpgi.2000.278.1.G10
12. Allais L, Kerckhof FM, Verschuere S, Bracke KR, De Smet R, Laukens D, et al. Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut. Environ Microbiol (2016) 18(5):1352-63. doi:10.1111/1462-2920.12934
13. Biedermann L, Brülisauer K, Zeitz J, Frei P, Scharl M, Vavricka SR, et al. Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH. Inflamm Bowel Dis (2014) 20:1496-501. doi:10.1097/MIB.0000000000000129
14. Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol (2005) 43:3380-9. doi:10.1128/JCM.43.7.3380-3389.2005
15. Zuo L, Li Y, Wang H, Wu R, Zhu W, Zhang W, et al. Cigarette smoking is associated with intestinal barrier dysfunction in the small intestine but not in the large intestine of mice. J Crohns Colitis (2014) 8:1710-22. doi:10.1016/j.crohns.2014.08.008
16. Ma L, Chow JY, Cho CH. Cigarette smoking delays ulcer healing: role of constitutive nitric oxide synthase in rat stomach. Am J Physiol (1999) 276:G238-48.
17. Lee H-M, Kim C-W, Hwang K-A, Choi D-W, Choi K-C. Three components of cigarette smoke altered the growth and apoptosis of metastatic colon cancer cells via inducing the synthesis of reactive oxygen species and endoplasmic reticulum stress. Environ Toxicol Pharmacol (2016) 45:80-9. doi:10.1016/j.etap.2016.05.016
18. Wang H, Ma L, Li Y, Cho CH. Exposure to cigarette smoke increases apoptosis in the rat gastric mucosa through a reactive oxygen species-mediated and p53-independent pathway. Free Radic Biol Med (2000) 28:1125-31. doi:10.1016/S0891-5849(00)00207-0
19. Verschuere S, Bracke KR, Demoor T, Plantinga M, Verbrugghe P, Ferdinande L, et al. Cigarette smoking alters epithelial apoptosis and immune composition in murine GALT. Lab Invest (2011) 91:1056-67. doi:10.1038/labinvest.2011.74
20. Oberg M, Jaakkola MS, Woodward A, Peruga A, Prüss-Ustün A. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet (2011) 377:139-46. doi:10.1016/S0140-6736(10)61388-8
21. Ueno A, Jijon H, Traves S, Chan R, Ford K, Beck PL, et al. Opposing effects of smoking in ulcerative colitis and Crohn's disease may be explained by differential effects on dendritic cells. Inflamm Bowel Dis (2014) 20:800-10. doi:10.1097/MIB.0000000000000018
22. Allais L, De Smet R, Verschuere S, Talavera K, Cuvelier CA, Maes T. Transient receptor potential channels in intestinal inflammation: what is the impact of cigarette smoking? Pathobiology (2017) 84:1-15. doi:10.1159/000446568
23. Lindell G, Farnebo LO, Chen D, Nexø E, Rask Madsen J, Bukhave K, et al. Acute effects of smoking during modified sham feeding in duodenal ulcer patients. An analysis of nicotine, acid secretion, gastrin, catecholamines, epidermal growth factor, prostaglandin E2, and bile acids. Scand J Gastroenterol (1993) 28:487-94. doi:10.3109/00365529309098254
24. Ogihara A, Kikuchi S, Hasegawa A, Kurosawa M, Miki K, Kaneko E, et al. Relationship between Helicobacter pylori infection and smoking and drinking habits. J Gastroenterol Hepatol (2000) 15:271-6. doi:10.1046/j.1440-1746.2000.02077.x
25. Hunsballe JM, Rittig S, Pedersen EB, Djurhuus JC. Smokeless nicotinergic stimulation of vasopressin secretion in patients with persisting nocturnal enuresis and controls. Scand J Urol Nephrol (2001) 35:117-21. doi:10.1080/003655901750170489
26. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet (2012) 380:1590-605. doi:10.1016/S0140-6736(12)60026-9
27. Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet (2012) 380:1606-19. doi:10.1016/S0140-6736(12)60150-0
28. Oberhuber G, Stangl PC, Vogelsang H, Schober E, Herbst F, Gasche C. Significant association of strictures and internal fistula formation in Crohn's disease. Virchows Arch (2000) 437:293-7. doi:10.1007/s004280000226
29. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology (2011) 140:1785-94. doi:10.1053/j.gastro.2011.01.055
30. Cosnes J. What is the link between the use of tobacco and IBD? Inflamm Bowel Dis (2008) 14(Suppl 2):S14-5. doi:10.1002/ibd.20555
31. Souza HSP, de & Fiocchi C. Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol (2016) 13:13-27. doi:10.1038/nrgastro.2015.186
32. Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut (2008) 57:1185-91. doi:10.1136/gut.2007.122143
33. Park JH, Peyrin-Biroulet L, Eisenhut M, Shin J. Il IBD immunopathogenesis: a comprehensive review of inflammatory molecules. Autoimmun Rev (2017) 16:416-26. doi:10.1016/j.autrev.2017.02.013
34. Liu JZ, Anderson CA. Genetic studies of Crohn's disease: past, present and future. Best Pract Res Clin Gastroenterol (2014) 28:373-86. doi:10.1016/j.bpg.2014.04.009
35. Cleynen I, Boucher G, Jostins L, Schumm LP, Zeissig S, Ahmad T, et al. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study. Lancet (2016) 387:156-67. doi:10.1016/S0140-6736(15)00465-1
36. Petnicki-Ocwieja T, Hrncir T, Liu YJ, Biswas A, Hudcovic T, Tlaskalova-Hogenova H, et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci U S A (2009) 106:15813-8. doi:10.1073/pnas.0907722106
37. Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, et al. A key role for autophagy and the autophagy gene ATG16l1 in mouse and human intestinal Paneth cells. Nature (2008) 456:259-63. doi:10.1038/nature07416
38. Deuring JJ, Fuhler GM, Konstantinov SR, Peppelenbosch MP, Kuipers EJ, de Haar C, et al. Genomic ATG16L1 risk allele-restricted Paneth cell ER stress in quiescent Crohn's disease. Gut (2014) 63:1081-91. doi:10.1136/gutjnl-2012-303527
39. Zorzi F, Monteleone I, Sarra M, Calabrese E, Marafini I, Cretella M, et al. Distinct profiles of effector cytokines mark the different phases of Crohn's disease. PLoS One (2013) 8:e54562. doi:10.1371/journal.pone.0054562
40. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology (2005) 129:550-64. doi:10.1053/j.gastro.2005.05.002
41. Heller F, Fromm A, Gitter AH, Mankertz J, Schulzke J-D. Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function. Mucosal Immunol (2008) 1(Suppl 1):S58-61. doi:10.1038/mi.2008.46
42. Fuss IJ, Strober W. The role of IL-13 and NK T cells in experimental and human ulcerative colitis. Mucosal Immunol (2008) 1(Suppl 1):S31-3. doi:10.1038/mi.2008.40
43. Fuss IJ, Joshi B, Yang Z, Degheidy H, Fichtner-Feigl S, de Souza H, et al. IL-13Ra2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis. Gut (2014) 63:1728-36. doi:10.1136/gutjnl-2013-305671
44. Tilg H, Kaser A. Failure of interleukin 13 blockade in ulcerative colitis. Gut (2015) 64:857-8. doi:10.1136/gutjnl-2015-309464
45. Takahashi F, Das KM. Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis. J Clin Invest (1985) 76:311-8. doi:10.1172/JCI111963
46. Duerr RH, Targan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, et al. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1991) 100:1385-91. doi:10.1016/0016-5085(91)90793-K
47. Biancone L, Mandal A, Yang H, Dasgupta T, Paoluzi AO, Marcheggiano A, et al. Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis. Gastroenterology (1995) 109:3-12. doi:10.1016/0016-5085(95)90263-5
48. Man SM, Kaakoush NO, Mitchell HM. The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol (2011) 8:152-68. doi:10.1038/nrgastro.2011.56
49. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology (2010) 139:1844-54.e1. doi:10.1053/j.gastro.2010.08.049
50. Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc (2006) 81:1462-71. doi:10.4065/81.11.1462
51. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci (1989) 34:1841-54. doi:10.1007/BF01536701
52. Beaugerie L, Massot N, Carbonnel F, Cattan S, Gendre JP, Cosnes J. Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol (2001) 96:2113-6. doi:10.1111/j.1572-0241.2001.03944.x
53. Lunney PC, Leong RWL. Review article: ulcerative colitis, smoking and nicotine therapy. Aliment Pharmacol Ther (2012) 36:997-1008. doi:10.1111/apt.12086
54. Ingram JR, Thomas GA, Rhodes J, Green JT, Hawkes ND, Swift JL, et al. A randomized trial of nicotine enemas for active ulcerative colitis. Clin Gastroenterol Hepatol (2005) 3:1107-14. doi:10.1016/S1542-3565(05)00849-9
55. Benowitz NL, Porchet H, Sheiner L, Jacob P. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Ther (1988) 44:23-8. doi:10.1038/clpt.1988.107
56. Lashner BA, Hanauer SB, Silverstein MD. Testing nicotine gum for ulcerative colitis patients. Experience with single-patient trials. Dig Dis Sci (1990) 35:827-32. doi:10.1007/BF01536795
57. Pullan RD, Rhodes J, Ganesh S, Mani V, Morris JS, Williams GT, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med (1994) 330:811-5. doi:10.1056/NEJM199403243301202
58. Sandborn WJ, Tremaine WJ, Leighton JA, Lawson GM, Zins BJ, Compton RF, et al. Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study. Aliment Pharmacol Ther (1997) 11:663-71. doi:10.1046/j.1365-2036.1997.00208.x
59. Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Cattan S, Gendre J. Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther (1999) 13:1403-11. doi:10.1046/j.1365-2036.1999.00630.x
60. Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, et al. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis (2003) 9:281-9. doi:10.1097/00054725-200309000-00001
61. Yamamoto T, Keighley MR. Smoking and disease recurrence after operation for Crohn's disease. Br J Surg (2000) 87:398-404. doi:10.1046/j.1365-2168.2000.01443.x
62. Cosnes J, Beaugerie L, Carbonnel F, Gendre JP. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology (2001) 120:1093-9. doi:10.1053/gast.2001.23231
63. Lewis CM, Whitwell SC, Forbes A, Sanderson J, Mathew CG, Marteau TM. Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn disease. J Med Genet (2007) 44:689-94. doi:10.1136/jmg.2007.051672
64. Davies PD, Yew WW, Ganguly D, Davidow AL, Reichman LB, Dheda K, et al. Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Trans R Soc Trop Med Hyg (2006) 100:291-8. doi:10.1016/j.trstmh.2005.06.034
65. O'Leary SM, Coleman MM, Chew WM, Morrow C, McLaughlin AM, Gleeson LE, et al. Cigarette smoking impairs human pulmonary immunity to mycobacterium tuberculosis. Am J Respir Crit Care Med (2014) 190:1430-6. doi:10.1164/rccm.201407-1385OC
66. Bokaba RP, Anderson R, Theron AJ, Tintinger GR. Cigarette smoke condensate attenuates phorbol ester-mediated neutrophil extracellular trap formation. Afr Health Sci (2017) 17:896-904. doi:10.4314/ahs.v17i3.33
67. Shaler CR, Horvath CN, McCormick S, Jeyanathan M, Khera A, Zganiacz A, et al. Continuous and discontinuous cigarette smoke exposure differentially affects protective Th1 immunity against pulmonary tuberculosis. PLoS One (2013) 8:e59185. doi:10.1371/journal.pone.0059185
68. Duan MC, Zhang JQ, Liang Y, Liu GN, Xiao J, Tang HJ, et al. Infiltration of IL-17-producing T cells and Treg cells in a mouse model of smoke-induced emphysema. Inflammation (2016) 39:1334-44. doi:10.1007/s10753-016-0365-8
69. Suenaert P, Bulteel V, Den Hond E, Hiele M, Peeters M, Monsuur F, et al. The effects of smoking and indomethacin on small intestinal permeability. Aliment Pharmacol Ther (2000) 14:819-22. doi:10.1046/j.1365-2036.2000.00754.x
70. Lee G, Jung KH, Shin D, Lee C, Kim W, Lee S, et al. Cigarette smoking triggers colitis by IFN-?+ CD4+ T cells. Front Immunol (2017) 8:1344. doi:10.3389/fimmu.2017.01344
71. Lakhan SE, Kirchgessner A. Anti-inflammatory effects of nicotine in obesity and ulcerative colitis. J Transl Med (2011) 9:129. doi:10.1186/1479-5876-9-129
72. Saeed RW, Varma S, Peng-NemeroffT, Sherry B, Balakhaneh D, Huston J, et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med (2005) 201:1113-23. doi:10.1084/jem.20040463
73. Mackern-Oberti JP, Riquelme SA, Llanos C, Schmidt CB, Simon T, Anegon I, et al. Heme oxygenase-1 as a target for the design of gene and pharmaceutical therapies for autoimmune diseases. Curr Gene Ther (2014) 14:218-35. doi:10.2174/1566523214666140424150308
74. Sheikh SZ, Hegazi RA, Kobayashi T, Onyiah JC, Russo SM, Matsuoka K, et al. An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis. J Immunol (2011) 186:5506-13. doi:10.4049/jimmunol.1002433
75. Monteleone I, Rizzo A, Sarra M, Sica G, Sileri P, Biancone L, et al. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology (2011) 141:237-48.e1. doi:10.1053/j.gastro.2011.04.007
76. Desreumaux P, Huet G, Zerimech F, Gambiez L, Balduyck M, Baron P, et al. Acute inflammatory intestinal vascular lesions and in situ abnormalities of the plasminogen activation system in Crohn's disease. Eur J Gastroenterol Hepatol (1999) 11:1113-9. doi:10.1097/00042737-199910000-00007
77. Dhillon AP, Anthony A, Sim R, Wakefield AJ, Sankey EA, Hudson M, et al. Mucosal capillary thrombi in rectal biopsies. Histopathology (1992) 21:127-33. doi:10.1111/j.1365-2559.1992.tb00360.x
78. Maor I, Rainis T, Lanir A, Lavy A. Oxidative stress, inflammation and neutrophil superoxide release in patients with Crohn's disease: distinction between active and non-active disease. Dig Dis Sci (2008) 53:2208-14. doi:10.1007/s10620-007-0141-6
79. Fritz T, Niederreiter L, Adolph T, Blumberg RS, Kaser A. Crohn's disease: NOD2, autophagy and ER stress converge. Gut (2011) 60:1580-8. doi:10.1136/gut.2009.206466
80. Hoefkens E, Nys K, John JM, Van Steen K, Arijs I, Van der Goten J, et al. Genetic association and functional role of Crohn disease risk alleles involved in microbial sensing, autophagy, and endoplasmic reticulum (ER) stress. Autophagy (2013) 9:2046-55. doi:10.4161/auto.26337
81. Adolph TE, Tomczak MF, Niederreiter L, Ko HJ, Böck J, Martinez-Naves E, et al. Paneth cells as a site of origin for intestinal inflammation. Nature (2013) 503:272-6. doi:10.1038/nature12599
82. Benjamin JL, Hedin CR, Koutsoumpas A, Ng SC, McCarthy NE, Prescott NJ, et al. Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm Bowel Dis (2012) 18:1092-100. doi:10.1002/ibd.21864
83. Eliakim R, Fan QX, Babyatsky MW. Chronic nicotine administration differentially alters jejunal and colonic inflammation in interleukin-10 deficient mice. Eur J Gastroenterol Hepatol (2002) 14:607-14. doi:10.1097/00042737-200206000-00005
84. Khutoryanskiy VV. Supramolecular materials: longer and safer gastric residence. Nat Mater (2015) 14:963-4. doi:10.1038/nmat4432